查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1464628

生物成像市场，按成像方式、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Bio-imaging Market, By Imaging Modality, By End user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年生物影像市场规模为62.0343亿美元，2024年至2032年复合年增长率为16.21%。

生物成像市场-市场动态

细胞生物学、生物化学和分子成像技术电脑分析的进步推动市场需求

全球生物成像市场在未来几年拥有巨大的成长潜力，该技术有望成为诊断实践的基石，带来许多创新和商机。生物成像技术被认为是医疗保健和生物医学研究领域的前景进步，有望推动经济高效、紧凑、便携式和用户友好的设备的开发。随着细胞生物学、生物化学和分子成像技术的电脑分析不断取得指数级进步，预计未来十年对这些技术的需求将大幅增长。生物成像市场的成长。随着预期寿命的延长和生活方式的改变，癌症、心血管疾病和神经系统疾病等非传染性疾病变得越来越普遍。例如，根据美国癌症协会2022年1月的报告，预计美国将有约19亿新诊断癌症病例和609,360例癌症相关死亡

生物成像市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 16.21% 左右的复合年增长率成长

根据成像模式细分，磁振造影预计将在 2023 年显示最大的市场份额

基于最终用户细分，2023年诊断中心为主导类型

按地区划分，北美是 2023 年的主要收入来源

生物成像市场細項分析：

全球生物成像市场根据成像方式、最终用户和地区进行细分。

根据影像方式，市场分为六类：磁振造影 (MRI)、电脑断层扫描 (CT)、正子断层扫描 (PET)、超音波、X 光、其他。到 2023 年，磁振造影 (MRI) 将成为一种主要的成像方式，以其多功能性、非侵入性和卓越的空间解析度而闻名，使其适合广泛的临床和研究最终用户。 MRI 技术能够以卓越的对比分辨率实现软组织、器官和解剖结构的详细可视化，在不同医学学科的诊断成像中确立了其不可或缺的地位。此外，MRI 能够透过功能性 MRI (fMRI) 和磁振造影 (MRS) 等方法提供功能和分子见解，进一步增强了其在临床和研究领域的功效。 MRI系统在医院、诊断中心和研究机构的广泛整合凸显了其在生物影像市场的霸主地位。

市场根据最终用户分为四类：医院和诊断中心、学术和研究机构、製药和生物技术公司、其他。就生物影像市场的最终用户细分市场而言，医院和诊断中心将在2023年成为主导细分市场。作用跨越无数的医疗条件。医院和诊断中心是初级医疗保健机构，患者在这里接受影像评估，以识别和管理疾病和损伤。随着慢性病发病率的不断上升以及对先进诊断影像服务的需求不断增长，医院和诊断中心持续投资于尖端的双成像设备和技术。此外，将生物成像系统整合到电子健康记录（EHR）和远距医疗平台中可以增强其在医疗保健服务中的可及性和有效性。因此，医院和诊断中心仍然是推动生物成像市场需求和扩张的主要最终用户。

生物成像市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。

生物影像市场-竞争格局：

在生物成像市场，公司经常建立策略合作伙伴关係，以推进其成像技术、扩大其产品范围并满足不同的客户需求。与学术机构和研究组织的合作促进了创新成像技术和应用的探索和验证。与医疗保健提供者的合作有助于将成像系统无缝整合到临床流程中，从而提高诊断精度和患者护理。此外，与製药公司的联盟透过提供用于筛选和分析的高通量成像解决方案来支持药物发现和开发计划。

最近的发展：

2024 年 1 月，领先的全自动仪器供应商 Biocare Medical 宣布与 HCR 成像技术的创造者 Molecular Instruments(R) (MI) 合作。此次合作将 Biocare Medical 在自动化生物成像系统方面的技术与 MI 的先进 HCR(TM) 产品套件相结合，在自动化原位杂交 (ISH) 和免疫组织化学 (IHC) 领域树立了新基准。

目录

第一章：生物影像市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按影像模式分類的生物成像市场片段
    • 最终用户的生物成像市场片段
    • 按国家/地区分類的生物成像市场片段
    • 按地区分類的生物成像市场片段
  • 竞争洞察

第 3 章：生物成像主要市场趋势

  • 生物影像市场驱动因素
    • 市场驱动因素的影响分析
  • 生物影像市场限制
    • 市场限制影响分析
  • 生物成像市场机会
  • 生物成像市场未来趋势

第 4 章：生物成像产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：生物影像市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：生物影像市场格局

  • 2023 年生物影像市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：生物成像市场 - 按影像模式

  • 概述
    • 按图像模式分類的细分市场份额分析
    • 磁振造影 (MRI)
    • 电脑断层扫描 (CT)
    • 正子断层扫描 (PET)
    • 超音波
    • X射线
    • 其他的

第 8 章：生物成像市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院和诊断中心
    • 学术及研究机构
    • 製药和生物技术公司
    • 其他的

第 9 章：生物成像市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美生物成像主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（以影像方式）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲生物成像主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（以影像方式）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区生物成像主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（以影像方式）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物成像主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（以图像方式）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲生物成像主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（以图像方式）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 生物成像产业

  • 竞争仪表板
  • 公司简介
    • Bracco Imaging SPA
    • Bayer HealthCare Pharmaceuticals
    • Esaote SpA
    • Digirad Corporation
    • FONAR Corporation
    • GE Healthcare
    • Hologic Inc
    • Hitachi Medical Corporation
    • Lantheus Medical Imaging, Inc.
    • Covidien Pharmaceuticals
    • Mindray Medical International Limited
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2425

REPORT HIGHLIGHT

Bio-imaging Market size was valued at USD 6,203.43 Million in 2023, expanding at a CAGR of 16.21% from 2024 to 2032.

Bio-imaging is the scientific discipline focused on obtaining functional and structural images of the human body. It employs various techniques and processes to capture detailed snapshots of human tissues and anatomy at the molecular level. This technology plays a crucial role in the diagnosis, treatment, and prevention of diseases by utilizing advanced imaging methods. Medical bio-imaging technology is widely utilized in the examination and diagnosis of numerous diseases, contributing to the establishment of a comprehensive database of the physiology and anatomy of living organisms for further research purposes. Molecular bio-imaging specifically deals with the spatial and temporal arrangement of macromolecules, incorporating various imaging technologies ranging from X-ray, elastography, and radiography to MRI, endoscopy, tactile imaging, positron emission tomography, and ultrasound.

Bio-imaging Market- Market Dynamics

Advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies to propel market demand

The global bio-imaging market holds immense growth potential in the coming years, with the technology poised to become a cornerstone of diagnostic practices, leading to numerous innovations and business opportunities. Bio-imaging techniques are considered promising advancements in healthcare and biomedical research, expected to drive the development of cost-effective, compact, portable, and user-friendly devices. As advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies continue to progress exponentially, the demand for these technologies is anticipated to rise significantly over the next decade.The increasing burden of chronic and infectious diseases worldwide is a major driving force behind the growth of the global bio-imaging market. With rising life expectancy and changing lifestyle patterns, non-communicable diseases such as cancer, cardiovascular diseases, and neurological disorders are becoming more prevalent. For example, according to a report by the American Cancer Society in January 2022, it is projected that there will be approximately 1.9 billion new cancer cases diagnosed and 609,360 cancer-related deaths in the U.S.

Bio-imaging Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.21% over the forecast period (2024-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging was predicted to show maximum market share in the year 2023

Based on End user segmentation, and diagnostic centers was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bio-imaging Market- Segmentation Analysis:

The Global Bio-imaging Market is segmented on the basis of Imaging Modality, End user, and Region.

The market is divided into six categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound, X-ray, Others. In 2023, Magnetic Resonance Imaging (MRI) emerges as a predominant imaging modality renowned for its versatility, non-invasiveness, and exceptional spatial resolution, rendering it suitable for a broad spectrum of clinical and research End users. The technology of MRI enables detailed visualization of soft tissues, organs, and anatomical structures with remarkable contrast resolution, establishing its indispensability in diagnostic imaging across diverse medical disciplines. Furthermore, MRI's capability to furnish functional and molecular insights through methodologies like functional MRI (fMRI) and magnetic resonance spectroscopy (MRS) further amplifies its efficacy in both clinical and research domains. The extensive integration of MRI systems in hospitals, diagnostic centers, and research institutions underscores its hegemony in the bio-imaging market.

The market is divided into four categories based on End user: Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, others. In terms of the end-user segment within the bio-imaging market, hospitals and diagnostic centers emerge as the dominant segment in 2023. This predominance is attributed to the indispensable role of bio-imaging technologies in clinical diagnosis, treatment planning, and disease monitoring across a myriad of medical conditions. Hospitals and diagnostic centers function as primary healthcare facilities where patients undergo imaging assessments for the identification and management of ailments and injuries. With the escalating incidence of chronic illnesses and the burgeoning demand for advanced diagnostic imaging services, hospitals and diagnostic centers persistently invest in cutting-edge bi-imaging equipment and technologies. Furthermore, the integration of bio-imaging systems into electronic health records (EHR) and telemedicine platforms enhances their accessibility and efficacy in healthcare delivery. Consequently, hospitals and diagnostic centers remain the principal end-users propelling demand and expansion in the bio-imaging market.

Bio-imaging Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bio-imaging Market- Competitive Landscape:

In the bio-imaging market, companies frequently establish strategic partnerships to advance their imaging technologies, broaden their product offerings, and cater to diverse customer requirements. Collaborations with academic institutions and research organizations facilitate the exploration and validation of innovative imaging techniques and applications. Partnerships with healthcare providers facilitate the seamless integration of imaging systems into clinical processes, enhancing diagnostic precision and patient care. Additionally, alliances with pharmaceutical companies support drug discovery and development initiatives by offering high-throughput imaging solutions for screening and analysis.

Recent Developments:

In January 2024, Biocare Medical, a leading provider of fully automated instrumentation, announced a collaboration with Molecular Instruments(R) (MI), the creator of HCR Imaging technology. This cooperation combines Biocare Medical's skill in automated bio-imaging systems with MI's suite of advanced HCR(TM) Products, founding a new benchmark in automated in situ hybridization (ISH) and immunohistochemistry (IHC).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIO-IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bracco Imaging S.P.A

Bayer HealthCare Pharmaceuticals

Esaote S.p.A

Digirad Corporation

FONAR Corporation

GE Healthcare

Hologic Inc

Hitachi Medical Corporation

Lantheus Medical Imaging, Inc.

Covidien Pharmaceuticals

Mindray Medical International Limited

Others

GLOBAL BIO-IMAGING MARKET, BY IMAGING MODALITY - MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Position Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Others

GLOBAL BIO-IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & diagnostic centers
  • Academic & research institutes
  • Pharmaceutical & biotech companies
  • Others

GLOBAL BIO-IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bio-imaging Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bio-imaging Market Snippet by Image Modality
    • 2.1.2.Bio-imaging Market Snippet by End User
    • 2.1.3.Bio-imaging Market Snippet by Country
    • 2.1.4.Bio-imaging Market Snippet by Region
  • 2.2.Competitive Insights

3.Bio-imaging Key Market Trends

  • 3.1.Bio-imaging Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bio-imaging Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bio-imaging Market Opportunities
  • 3.4.Bio-imaging Market Future Trends

4.Bio-imaging Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bio-imaging Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bio-imaging Market Landscape

  • 6.1.Bio-imaging Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bio-imaging Market - By Image Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Image Modality, 2023 & 2032 (%)
    • 7.1.2.Magnetic Resonance Imaging (MRI)
    • 7.1.3.Computed Tomography (CT)
    • 7.1.4.Position Emission Tomography (PET)
    • 7.1.5.Ultrasound
    • 7.1.6.X-ray
    • 7.1.7.Others

8.Bio-imaging Market - By End User

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2.Hospitals & diagnostic centers
    • 8.1.3.Academic & research institutes
    • 8.1.4.Pharmaceutical & biotech companies
    • 8.1.5.Others

9.Bio-imaging Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Bio-imaging Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Bio-imaging Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Bio-imaging Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Bio-imaging Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Bio-imaging Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Bio-imaging Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bracco Imaging S.P.A
    • 10.2.2.Bayer HealthCare Pharmaceuticals
    • 10.2.3.Esaote S.p.A
    • 10.2.4.Digirad Corporation
    • 10.2.5.FONAR Corporation
    • 10.2.6.GE Healthcare
    • 10.2.7.Hologic Inc
    • 10.2.8.Hitachi Medical Corporation
    • 10.2.9.Lantheus Medical Imaging, Inc.
    • 10.2.10.Covidien Pharmaceuticals
    • 10.2.11.Mindray Medical International Limited
    • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bio-imaging Market: Image Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Image Modality
  • TABLE Global Bio-imaging Market, by Image Modality 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Bio-imaging Market, by End User 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bio-imaging Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by End User, 2019-2032 (USD Million)